Wisconsin's Only DOL-OWCP Clinic Leads the Fight for Injured Workers in Wisconsin

August 21, 2025 9:30 AM

Advanced Care Specialists (ACS), Racine's premier provider of multidisciplinary medical care, is proud to announce a renewed focus on helping injured workers with a streamlined, patient-first approach that's changing the face of occupational injury treatment in Wisconsin.The Problem: Delays, Denials, and Disjointed CareEvery year, countless Wisconsin workers suffer injuries on the job, ranging from repetitive strain and back pain to traumatic...

Read more

Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs

August 21, 2025 9:00 AM

Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the veterinary market, today announced it is participating in the 2025 Animal Health Summit in support of the company's goal of securing a collaboration to expand the indication of Canalevia (crofelemer delayed-release tablets) from treatment of chemotherapy-induced diarrhea (CID) in dogs to treatment of general diarrhea in dogs. Canalevia, under the name...

Read more

RSMD Medical Aesthetics Reopens in Capitola Following Fire, With New Location and Renewed Commitment to Patients

August 21, 2025 9:00 AM

RSMD Medical Aesthetics has officially reopened in a new location at 828 Bay Avenue, Capitola, CA 95010, just across the street from its former clinic, following a July 28 fire that forced the practice to relocate.The fire originated in Sushi Garden, the restaurant below RSMD's previous office. While the upstairs clinic sustained damage, no patients or staff were present, and no injuries occurred. Thanks to the swift action of the Central Fire...

Read more

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

August 21, 2025 8:12 AM

Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel neuro-active peptide therapies, today announced completion of first dose injection for all study subjects in the multiple-dose portion of its ongoing Phase I clinical trial of PT00114. The company expects to complete dosing by the end of August, with topline safety data anticipated by the end of September, supporting advancement into Phase 2 efficacy...

Read more

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan

August 21, 2025 8:02 AM

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that PrCABTREO™ (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgaris,1 is now available to beneficiaries of the public drug plans of Quebec and Saskatchewan.This new public drug plan availability of CABTREO is in addition to...

Read more

The Billionaire Face is Real-But It's Not What You Think, Says Top Facial Plastic Surgeon Dr. Shervin Naderi

August 21, 2025 8:00 AM

The so-called "Mar-a-Lago Face" has become a viral shorthand for an aesthetic seen throughout Palm Beach society-tight, smooth, and unmistakably maintained. But according to world-renowned facial plastic surgeon Dr. Shervin Naderi, the term is often misused and misunderstood."The Mar-a-Lago Face isn't one look-it's two," says Dr. Naderi. "One version is a badge of wealth and access to top-tier aesthetic care. The other is the result of...

Read more

Sound Physicians Unveils New Brand Identity, Reflecting More Than Two Decades of Patient-Centric Partnership and a Bold Vision for the Future

August 21, 2025 8:00 AM

For over two decades, Sound Physicians has worked in tandem with hospitals and healthcare organizations to create practices that unlock quality, affordable, and dignified care for all patients, while driving financial sustainability for their partners. Today, they proudly unveil a refreshed brand that honors their origins in hospital medicine while encompassing their expanded expertise across the acute and post-acute care continuum.The rebrand...

Read more

Moderna to Present at Upcoming Conferences in September 2025

August 21, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:Morgan Stanley's 23rd Annual Global Healthcare Conference, on Monday, September 8th at 10:00am ETBernstein Insights: Healthcare Leaders and Disruptors, on Thursday, September 25th at 10:30am ETA live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna...

Read more

Bionic Bloom Launches Suite of Intensive Outpatient Programs Focused on Personalized, Integrative Care

August 21, 2025 6:00 AM

Bionic Bloom, the nation's first legal psilocybin therapy center and a leader in integrative mental health, today announced an expanded suite of Intensive Outpatient Programs (IOPs) designed to deliver personalized, multidisciplinary care with measurable outcomes. The new IOPs apply Bionic Bloom's Empowerment-Based Integrated Treatment (EBiT) model across key clinical needs: neurodivergent burnout, veteran reintegration, dual diagnosis (bipolar...

Read more

IRLAB Appoints Roy Jonebrant as Interim CFO

August 21, 2025 5:20 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that Roy Jonebrant will take over as acting CFO on September 1, 2025.Roy Jonebrant replaces Viktor Siewertz, who is leaving IRLAB to take a senior position in another company, as previously announced."We are very pleased that Roy Jonebrant will take on the role of interim CFO during the recruitment...

Read more

Interim Report H1 2025: Group Revenue and Earnings Record-High

August 21, 2025 1:50 AM

Gubra (CPH:GUBRA) - Today, Gubra released its interim report for the first half of 2025. Group revenue and EBIT in the first half of 2025 were record-high and amounted to DKK 2.5 billion and DKK 2.3 billion, respectively. This can be compared to the same period last year with DKK 121 million in revenue and DKK -21 million in EBIT. A very significant improvement with the recognition of the upfront payment in the AbbVie-deal as the main...

Read more

Half-Year Report 2025: Orviglance NDA Submission Approaching

August 21, 2025 1:50 AM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker: ACE) today published its Half-Year Report for 2025 (January - June), which is now available on the company's website: Financial Reports - ASCELIAKEY EVENTS IN Q2 2025Study on Orviglance ® target patients accepted for presentation at the ISPOR 2025 conferencePublication of scientific article on Orviglance in Investigative RadiologyAscelia Pharma receives gross proceeds of SEK 43 million...

Read more

Cantargia Publishes Half-Year Report 2025

August 21, 2025 1:20 AM

Cantargia AB (publ) [Nasdaq Stockholm:CANTA] (Cantargia) today issued the interim report for January to June 2025."I started my tenure as interim CEO with a strong focus on looking to deliver at least one transformative transaction during 2025. I am delighted for all Cantargia's stakeholders, including our loyal shareholders, our employees and patients in need, that we have been able to deliver on this goal with the Otsuka agreement. Not only...

Read more

Medicure Reports Financial Results for Quarter Ended June 30, 2025

August 20, 2025 5:30 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2025.Quarter Ended June 30, 2025 Highlights:Recorded total net revenue of $6.7 million during the quarter ended June 30, 2025 compared to $5.2...

Read more

Neurocare Group Receives FDA Clearance for Treatment of OCD With Its Transcranial Magnetic Stimulation (TMS) Devices

August 20, 2025 3:15 PM

neurocare group AG ("neurocare" or the "Company"), a best practice platform for mental health and performance, today announced it has received FDA clearance for the treatment of Obsessive Compulsive Disorder (OCD) using its Apollo TMS Therapy devices, a state-of-the-art system in Transcranial Magnetic Stimulation.OCD affects about 1.2% of U.S. adults in any given year, and approximately 2.3%-roughly one in 40 people-experience it at some point...

Read more

iSpecimen's $6M Valuation Doesn't Reflect the Business-Let Alone the $200M Treasury (NASDAQ: ISPC)

August 20, 2025 1:15 PM

A share price of $1.11. A $6.1 million market cap. Just 5.54 million shares outstanding. And a newly announced $200 million digital treasury. On paper, the disconnect between price and intrinsic value, let alone inherent potential, is hard to miss. But the real takeaway isn't just the contrast. It's what that contrast says about iSpecimen Inc. (NASDAQ:ISPC): a company with a functioning platform, measurable revenue, and real-world utility that...

Read more

Record Quarter for Gubra, but Revised Outlook for the CRO Business

August 20, 2025 11:45 AM

Revenue and earnings for Gubra Group (CPH:GUBRA) have been record-high in the second quarter of 2025 driven by the outlicensing deal with AbbVie in our Discovery & Partnerships business. While the CRO business also experienced revenue growth in the second quarter of 12% year-over-year, the full-year outlook for CRO revenue in 2025 has been revised to be slightly below CRO revenue level in 2024 (previous outlook 10-20% revenue growth). Outlook...

Read more

AI Tools Cut Disputes and Halve Settlement Times in Value-Based Care

August 20, 2025 9:15 AM

Artificial intelligence (AI) is rapidly transforming the economics of value-based care (VBC), according to a new Black Book flash survey. The August 2025 poll collected responses from 108 payer professionals directly responsible for acquiring and managing value-based care software and services. Ninety-four represented organizations with active VBC arrangements, yielding a strong front-line perspective on reconciliation.The survey confirms that...

Read more

Tampa MD, PhD Meegan Gruber, Board-Certified Plastic Surgeon, Explains the Title Tricks and How to Stay Safe

August 20, 2025 9:00 AM

Confusing titles. Look-alike "boards." Office-based workarounds. Meegan Gruber, MD, PhD, a board-certified plastic surgeon and physician-scientist who specializes in Awake Surgery, launches an open patient-safety initiative to help consumers distinguish between marketing tactics and medical procedures before undergoing liposuction, tummy tucks, facelifts, and other procedures. Dr. Gruber holds ABPS certification in plastic surgery and dual...

Read more

Vastian Partners with ACHC to Automate Accreditation Standards within Readiness Platform

August 20, 2025 9:00 AM

Vastian, a leading provider of Quality management software for hospitals and laboratories, today announced its partnership with the Accreditation Commission for Health Care (ACHC) to streamline the regulatory compliance process for acute care and critical access hospitals. Vastian has integrated the ACHC accreditation standards within its Quality management system application, Vastian Readiness, allowing hospitals to access and adhere to the...

Read more